NCT06461442
Efficacy and Safety of Cryotherapy Versus 5-Fluorouracil in the Treatment of Actinic Keratosis
Enrolling by Invitation
PHASE4Ages 18+InterventionalTreatmentUniversity of California, DavisInvestigator-initiated
~73 participants
Updated 2026-07-06 on ClinicalTrials.gov
What's tested:Cryotherapy5Fluorouracil
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Partial clearance rate
Measured over 3 months and 12 months
Conditions
Where it's being run
1 sites across 1 statesCalifornia1
Study leadership
- Daniel Eisen, MD · PRINCIPAL_INVESTIGATOR · UC Davis Department of Dermatology
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
18 years of age or older
Has a clinical diagnosis of 10 or more AKs in the head, neck, or extremities areas
Able to give informed consent themselves
Willing to return for follow up visits
Exclusion
Cognitively Impaired
Incarcerated
Non-English speakers
Immuno-comprised status
Received any kind of treatment for AK within the past 2 months
Use of systemic retinoids within the past 3 months
Suspicion of cancer in the target area
Porphyria
Genetic skin cancer disorders
Allergy to trial drugs or peanut/soy products
Pregnancy or breast-feeding
What this trial measures
- Partial clearance rate3 months and 12 months
Proportion of patients with at least a 75% reduction in the number of baseline AK lesions within the selected treatment area